Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Indaptus Therapeutics Inc. Common Stock
INDP | US
2.15
USD0.23
11.98%
INDP | US
About Indaptus Therapeutics Inc. Common Stock
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
02/06/2026
Close
2.15
Open
1.87
High
2.26
Low
1.81
Indaptus Therapeutics Inc. a clinical biotechnology company develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate is Decoy20 used to produce single agent activity and/or combination therapy-based durable responses of lymphoma hepatocellular colorectal and pancreatic tumors as well as chronic hepatitis B virus and human immunodeficiency virus infection which is in Phase 2 clinical trial. The company was formerly known as Intec Parent Inc. and changed its name to Indaptus Therapeutics Inc. in August 2021. Indaptus Therapeutics Inc. is headquartered in New York New York.
View LessINDP | US
Risk
159.9
Sharpe
-0.52
Luna's Score
49/100
Recommendation
Hold
Luna says (INDP | US)
What's Working
Strength based on increasing price with high volume
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
High Short-term Volatility
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
Risk Meter
10 days
213.8%1 month
159.9%3 months
141.9%6 months
133.1%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.50
Debt to equity
0.02
Debt to assets
0.02
Ent. to EBITDA
1.03
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-16.48M
MarketCap
21.92M
MarketCap(USD)
21.92M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-127.04
Short ratio
1.54
Short perc.
0.45
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
1.34
Range1M
1.44
Range3M
2.90
Volumes: Market Activity
Rel. volume
1.02
Price X volume
227.22K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 1.03 | - | Expensive |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 2.50 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 141.90 | - | Riskier |
| Debt to Equity | 0.02 | -1.23 | Expensive |
| Debt to Assets | 0.02 | 0.25 | Cheaper |
| Market Cap | 21.92M | - | Emerging |
